APMDNasdaqPharmaceutical Preparations

Apnimed, Inc. (APMD) earnings date, market-implied expected move, and options open interest by expiry

15.05

−0.35 · −2.30%

post 15.29 +1.62%

Closed19:58 ET

Open15.75Volume530,945Mkt cap$498.2M

Day14.83 – 16.2433%52-wk15.09 – 35.291%

APMD

Apnimed, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

News

95dAPMD — trading halt (LUDP) · resumed 11:54 ET

News

Next report

Last report

−2.47%

shaded = implied · ▲▼ = realized

Sep 8 '26 · confirmed

Implied vs realized

Largest filed tie

—

13F top-10 QoQ

—

Top fund weight

—

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

No upcoming report date for Apnimed (APMD). No implied move.

Implied vs realized

1 report

—≥ implied

Q2 FY26Sep 8 '26confirmed—▼−2.47%—

quarterimplied−5%0+5%realized×

Q2 FY26—▼−2.47%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

No open-interest data.

Positioning

Linked exposure

No linked exposure.

Linked exposure

Revenue flow

as filedQ2 FY26

1042.51%as filednet margin · revenue −29.40% YoY

Revenue$12M—

Gross profit$12M100.00%—

Operating income−$12M−96.89%—

Pre-tax income$126M—

Net income$126M1042.51%—

Cost of revenue$0—

Operating expenses$24M—

Tax$0—

Other income$140M—

Source: SEC filings · standardized · QE Jun 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 19:45 ET

Intraday

Event sensitivity

—

Earnings history

EPS 3.91 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Sep 8 '26 · confirmed	3.91	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod